A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
Clinical trial NCT07107490 · RECRUITING
Trial details
- NCT number
- NCT07107490
- Sponsor
- Chugai Pharmaceutical
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-08
- Primary completion
- 2028-09-30
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.